Q2 2018 Holdings
Filed 2018-08-13 | 180 holdings | $266.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $117.2M | 403,955 | 44.0% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $47.6M | 513,658 | 17.9% |
| Boston Scientific Corporation(BSX) | Common | 101137107 | $15.0M | 457,585 | 5.6% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $13.2M | 140,538 | 5.0% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $12.8M | 130,376 | 4.8% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $11.1M | 272,400 | 4.2% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $10.2M | 855,468 | 3.8% |
| Cellectis S.A.(CLLS) | Sponsored ADR | 15117K103 | $9.0M | 317,950 | 3.4% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $8.4M | 54,785 | 3.2% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $3.4M | 240,843 | 1.3% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $3.2M | 38,931 | 1.2% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $2.9M | 43,914 | 1.1% |
| Akebia Therapeutics, Inc.(AKBA) | Common | 00972D105 | $2.7M | 266,612 | 1.0% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $2.5M | 22,670 | 1.0% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $2.4M | 639,370 | 0.9% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $1.4M | 93,689 | 0.5% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $677.0K | 203,935 | 0.3% |
| Agios Pharmaceuticals, Inc.(AGIO) | Common | 00847X104 | $237.0K | 2,810 | 0.1% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $146.2K | 2,063,699 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $129.3K | 700,588 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $108.4K | 893,082 | 0.0% |
| Unitedhealth Group Incorporated(UNH) | Common | 91324P102 | $104.3K | 425,317 | 0.0% |
| Celgene Corporation(CELG) | Common | 151020104 | $99.4K | 1,251,470 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $98.8K | 581,522 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $85.6K | 2,359,687 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $79.5K | 284,492 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $77.9K | 1,284,022 | 0.0% |
| Mylan N.V. | Shares | N59465109 | $59.9K | 1,657,017 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $54.4K | 438,416 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $50.5K | 146,237 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $43.2K | 645,442 | 0.0% |
| Allergan plc | Shares | G0177J108 | $41.5K | 248,836 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $38.2K | 627,019 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $36.3K | 423,693 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $36.0K | 651,030 | 0.0% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $33.3K | 390,108 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $31.6K | 152,695 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $31.3K | 105,053 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $31.0K | 234,489 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $28.2K | 129,608 | 0.0% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $27.3K | 778,888 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $26.5K | 269,769 | 0.0% |
| Teva Pharmaceutical Industries Limited(TEVA) | Sponsored ADR | 881624209 | $26.4K | 1,083,843 | 0.0% |
| Anthem, Inc.(ELV) | Common | 036752103 | $26.3K | 110,633 | 0.0% |
| Spdr S&P Biotech ETF(XBI) | S&P Biotech ETF | 78464A870 | $23.8K | 250,460 | 0.0% |
| CVS Health Corporation(CVS) | Common | 126650100 | $23.6K | 366,521 | 0.0% |
| Stryker Corporation(SYK) | Common | 863667101 | $23.1K | 136,631 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $22.8K | 184,819 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | Common | 78667J108 | $22.5K | 143,614 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $22.3K | 295,820 | 0.0% |